February 11, 2022 07:16 AM ESTUpdated 09:02 AM
Coronavirus

Covid-19 roundup: US to pay $725M for Eli Lil­ly's new mAb, if au­tho­rized; WHO chief sci­en­tist says more vari­ants are com­ing

Zachary Brennan

Senior Editor

Eli Lil­ly had a big day in the Wash­ing­ton, DC area yes­ter­day. Af­ter get­ting pum­meled at an ad­comm for sub­mit­ting a can­cer drug can­di­date …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs 

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times